Ischemic Preconditioning by Caspase Cleavage of Poly(ADP-Ribose) Polymerase-1
Philippe Garnier(Inserm), Raymond A. Swanson(San Francisco VA Medical Center)
Cited by 79
Related Papers
Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases
|British Journal of Pharmacology|2017|210
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration
|Nature Immunology|2018|210
Hypoglycemic Neuronal Death and Cognitive Impairment Are Prevented by Poly(ADP-Ribose) Polymerase Inhibitors Administered after Hypoglycemia
|Journal of Neuroscience|2003|206
Nuclear Factor Erythroid 2-Related Factor 2 Facilitates Neuronal Glutathione Synthesis by Upregulating Neuronal Excitatory Amino Acid Transporter 3 Expression
|Journal of Neuroscience|2011|96
Brain energy metabolism: A roadmap for future research
|Journal of Neurochemistry|2024|94